Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cerebrovascular Disorders

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    October 2018
  1. YIN X, Wang D
    Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    


  2. JIA L, Ji H, Li R
    Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    



  3. Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    



  4. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1579-1581.
    PubMed     Text format    


  5. WUSSLER D, du Fay de Lavallaz J, Mueller C
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1580.
    PubMed     Text format    


  6. YIN X, Wang D
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1579-1580.
    PubMed     Text format    


    September 2018
  7. HARLOFF A, Schlachetzki F
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986-7.
    PubMed     Text format    


  8. SU Q, Li Q
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986.
    PubMed     Text format    


  9. GIRGIS M, Jelaidan I
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986.
    PubMed     Text format    



  10. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986-987.
    PubMed     Text format    


    August 2018
  11. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Text format     Abstract available


  12. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Text format     Abstract available


  13. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Text format     Abstract available


    July 2018
  14. TAYLOR JB, Prager LM, Quijije NV, Schaefer PW, et al
    Case 21-2018: A 61-Year-Old Man with Grandiosity, Impulsivity, and Decreased Sleep.
    N Engl J Med. 2018;379:182-189.
    PubMed     Text format    


    June 2018
  15. TRUFFAUT L, Lefebvre P
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2018;378:2517.
    PubMed     Text format    



  16. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMx180019.
    PubMed     Text format    


    May 2018
  17. HART RG, Sharma M, Mundl H, Kasner SE, et al
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1802686.
    PubMed     Text format     Abstract available


  18. AMARENCO P, Lavallee PC, Monteiro Tavares L, Labreuche J, et al
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1802712.
    PubMed     Text format     Abstract available


  19. THOMALLA G, Simonsen CZ, Boutitie F, Andersen G, et al
    MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1804355.
    PubMed     Text format     Abstract available


  20. GROTTA JC
    Antiplatelet Therapy after Ischemic Stroke or TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMe1806043.
    PubMed     Text format    


  21. JOVIN TG
    MRI-Guided Intravenous Alteplase for Stroke - Still Stuck in Time.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMe1805796.
    PubMed     Text format    


  22. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Text format     Abstract available


  23. VINNY PW, Vishnu VY, Srivastava MVP
    Thrombectomy for Stroke with Selection by Perfusion Imaging.
    N Engl J Med. 2018;378:1849.
    PubMed     Text format    



  24. Thrombectomy for Stroke with Selection by Perfusion Imaging.
    N Engl J Med. 2018;378:1849-1850.
    PubMed     Text format    


    April 2018
  25. MI MY, Block PC, Broderick JP
    PFO Closure for Cryptogenic Stroke.
    N Engl J Med. 2018;378:1639-1642.
    PubMed     Text format    


  26. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Text format     Abstract available


  27. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed     Text format    


  28. MORITA H, Komuro I
    Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    N Engl J Med. 2018;378:1561.
    PubMed     Text format    


  29. NIKOLAEV SI, Fish JE, Radovanovic I
    Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    N Engl J Med. 2018;378:1561-1562.
    PubMed     Text format    


  30. ANDERSON CS, Woodward M, Chalmers J
    More on Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
    N Engl J Med. 2018;378:1465-1466.
    PubMed     Text format    


    March 2018
  31. VINNY PW, Vishnu VY, Padma Srivastava MV
    Thrombectomy 6 to 24 Hours after Stroke.
    N Engl J Med. 2018;378:1161.
    PubMed     Text format    


  32. JOVIN TG, Nogueira RG
    Thrombectomy 6 to 24 Hours after Stroke.
    N Engl J Med. 2018;378:1161-1162.
    PubMed     Text format    


  33. MEHRA MR, Goldstein DJ, Uriel N, Cleveland JC Jr., et al
    Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
    N Engl J Med. 2018 Mar 11. doi: 10.1056/NEJMoa1800866.
    PubMed     Text format     Abstract available


  34. CAMARGO EC, Huang SY, Karaa A, Rosenbaum MW, et al
    Case 7-2018: A 25-Year-Old Man with New-Onset Seizures.
    N Engl J Med. 2018;378:941-948.
    PubMed     Text format    


    February 2018
  35. BAUASHVILI A, Evans AT
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:485.
    PubMed     Text format    


  36. DEKKERS T, Lafeber M, Kramers C
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484-5.
    PubMed     Text format    


  37. WANG X, Karnieg T
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484.
    PubMed     Text format    



  38. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484-486.
    PubMed     Text format    


  39. PICCINI JP, Jones WS
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:486.
    PubMed     Text format    


    January 2018
  40. ALBERS GW, Marks MP, Kemp S, Christensen S, et al
    Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.
    N Engl J Med. 2018 Jan 24. doi: 10.1056/NEJMoa1713973.
    PubMed     Text format     Abstract available


  41. NIKOLAEV SI, Vetiska S, Bonilla X, Boudreau E, et al
    Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    N Engl J Med. 2018;378:250-261.
    PubMed     Text format     Abstract available


  42. ZHENG MX, Hua XY, Feng JT, Li T, et al
    Trial of Contralateral Seventh Cervical Nerve Transfer for Spastic Arm Paralysis.
    N Engl J Med. 2018;378:22-34.
    PubMed     Text format     Abstract available


    December 2017
  43. BRAEMSWIG TB, Scheitz JF, Nolte CH
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2599.
    PubMed     Text format    


  44. COSMI D, Mariottoni B, Cosmi F
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2598-2599.
    PubMed     Text format    


  45. MAS JL, Derumeaux G, Chatellier G
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2599-2600.
    PubMed     Text format    


  46. CUCULICH PS, Schill MR, Kashani R, Mutic S, et al
    Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia.
    N Engl J Med. 2017;377:2325-2336.
    PubMed     Text format     Abstract available


  47. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed     Text format    


    November 2017
  48. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed     Text format    


  49. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Text format     Abstract available


  50. NOGUEIRA RG, Jadhav AP, Haussen DC, Bonafe A, et al
    Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.
    N Engl J Med. 2017 Nov 11. doi: 10.1056/NEJMoa1706442.
    PubMed     Text format     Abstract available


  51. HACKE W
    A New DAWN for Imaging-Based Selection in the Treatment of Acute Stroke.
    N Engl J Med. 2017 Nov 11. doi: 10.1056/NEJMe1713367.
    PubMed     Text format    


  52. GOLDSTONE AB, Chiu P, Baiocchi M, Lingala B, et al
    Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.
    N Engl J Med. 2017;377:1847-1857.
    PubMed     Text format     Abstract available


    October 2017
  53. AKIYAMA M
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493-4.
    PubMed     Text format    


  54. GONZALES-GAY MA, Loricera J, Blanco R
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed     Text format    


  55. STONE JH, Klearman M, Collinson N
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1494-1495.
    PubMed     Text format    



  56. Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed     Text format    


    September 2017
  57. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Text format     Abstract available


  58. SIBON I, Gerardin P, Gauthier A
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1101.
    PubMed     Text format    


  59. FELDMAN WB, Chiong W, Kim SYH
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1101-2.
    PubMed     Text format    


  60. FARB A, Ibrahim NG, Zuckerman BD
    Patent Foramen Ovale after Cryptogenic Stroke - Assessing the Evidence for Closure.
    N Engl J Med. 2017;377:1006-1009.
    PubMed     Text format    


  61. MAS JL, Derumeaux G, Guillon B, Massardier E, et al
    Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    N Engl J Med. 2017;377:1011-1021.
    PubMed     Text format     Abstract available


  62. SAVER JL, Carroll JD, Thaler DE, Smalling RW, et al
    Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
    N Engl J Med. 2017;377:1022-1032.
    PubMed     Text format     Abstract available


  63. TAITO S, Yamauchi K
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1102.
    PubMed     Text format    



  64. Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1102-3.
    PubMed     Text format    


  65. SONDERGAARD L, Kasner SE, Rhodes JF, Andersen G, et al
    Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
    N Engl J Med. 2017;377:1033-1042.
    PubMed     Text format     Abstract available


  66. ROPPER AH
    Tipping Point for Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:1093-1095.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: